These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33129654)

  • 1. Evaluation of Clinician Contouring for Pancreatic Stereotactic Ablative Radiotherapy During a Contouring Workshop Organised by the Royal College of Radiologists.
    Slevin F; Beasley M; Speight R; Lilley J; Murray L; Hawkins M; Radhakrishna G; Henry A
    Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e196-e197. PubMed ID: 33129654
    [No Abstract]   [Full Text] [Related]  

  • 2. Restricted bowel loop contouring: Improving efficiency in radiotherapy contouring for abdomino-pelvic Stereotactic Ablative Radiotherapy (SABR).
    Clarke E; Howells R; Beasley M; Murray L
    Clin Transl Radiat Oncol; 2020 Sep; 24():60-64. PubMed ID: 32637661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evaluation Report on Radiotherapy Contouring Workshops During the Royal College of Radiologists' Annual Meeting 2018.
    Iqbal MS; Hothi A; Evans ES; Gilson D; Laws K; Saleem W; Salem A; Soh FY; Woolf D; Radhakrishna G
    Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):276. PubMed ID: 31627976
    [No Abstract]   [Full Text] [Related]  

  • 4. Contouring experiences amongst Australian, New Zealand and Singaporean radiation oncology trainees. Is it enough? What next?
    Leung J; Lehman M
    J Med Imaging Radiat Oncol; 2019 Jun; 63(3):383-389. PubMed ID: 30720245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium.
    Balgobind BV; Visser J; Grehn M; Marquard Knap M; de Ruysscher D; Levis M; Alcantara P; Boda-Heggemann J; Both M; Cozzi S; Cvek J; Dieleman EMT; Elicin O; Giaj-Levra N; Jumeau R; Krug D; Algara López M; Mayinger M; Mehrhof F; Miszczyk M; Pérez-Calatayud MJ; van der Pol LHG; van der Toorn PP; Vitolo V; Postema PG; Pruvot E; Verhoeff JC; Blanck O
    Radiother Oncol; 2023 Dec; 189():109949. PubMed ID: 37827279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence for Radiotherapy Auto-Contouring: Current Use, Perceptions of and Barriers to Implementation.
    Hindocha S; Zucker K; Jena R; Banfill K; Mackay K; Price G; Pudney D; Wang J; Taylor A
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):219-226. PubMed ID: 36725406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice.
    Dunne EM; Lo SS; Liu MC; Bergman A; Kosztyla R; Chang EL; Chang UK; Chao ST; Dea N; Faruqi S; Ghia AJ; Redmond KJ; Soltys SG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):114-120. PubMed ID: 34454046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
    Adair Smith G; Dunlop A; Alexander SE; Barnes H; Casey F; Chick J; Gunapala R; Herbert T; Lawes R; Mason SA; Mitchell A; Mohajer J; Murray J; Nill S; Patel P; Pathmanathan A; Sritharan K; Sundahl N; Tree AC; Westley R; Williams B; McNair HA
    Radiother Oncol; 2023 Mar; 180():109457. PubMed ID: 36608770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Ablative Body Radiotherapy as a Bridge to Liver Transplant for Hepatocellular Carcinoma: Preliminary Results of Başkent University Experience.
    Yavas G; Ayvazoglu Soy EH; Coskun M; Onal C; Boyvat F; Haberal M
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):39-45. PubMed ID: 35384806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and reproducibility of substituting oral contrast with water for duodenal volume delineation in patients undergoing pancreatic stereotactic body radiotherapy.
    Wu G; Verma V; Haefner MF; Li S; Lin C
    J Gastrointest Oncol; 2017 Aug; 8(4):705-709. PubMed ID: 28890821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk.
    Song JY; Chie EK; Kang SH; Jeon YJ; Ko YA; Kim DY; Kang HC
    Radiat Oncol J; 2022 Dec; 40(4):242-250. PubMed ID: 36606301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer.
    Henderson DR; Tree AC; Harrington KJ; van As NJ
    Medicines (Basel); 2018 Apr; 5(2):. PubMed ID: 29621134
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereotactic body radiotherapy in pancreatic adenocarcinoma.
    de la Pinta C
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):14-19. PubMed ID: 36990839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
    Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
    J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy: overview of the 2010 Royal College of Radiologists' annual scientific meeting.
    Schick U; Richards T; Miah A; Nutting CM
    Clin Oncol (R Coll Radiol); 2011 Apr; 23(3):165-7. PubMed ID: 21324657
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiotherapy for Hepatocellular Carcinoma in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
    Mitin T; Degnin C; Chen Y; Shirvani S; Gillespie E; Hoffe S; Latifi K; Nabavizadeh N; Dengina N; Chernich M; Usychkin S; Kharitonova E; Egorova Y; Pankratov A; Tsimafeyeu I; Thomas CR; Tjulandin S; Likhacheva A
    J Cancer Educ; 2020 Feb; 35(1):105-111. PubMed ID: 30467774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multidisciplinary Evaluation of a Web-based eLearning Training Programme for SAFRON II (TROG 13.01): a Multicentre Randomised Study of Stereotactic Radiotherapy for Lung Metastases.
    Pham D; Hardcastle N; Foroudi F; Kron T; Bressel M; Hilder B; Chesson B; Oates R; Montgomery R; Ball D; Siva S
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e101-8. PubMed ID: 27116931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.
    Mou B; Beltran CJ; Park SS; Olivier KR; Furutani KM
    PLoS One; 2014; 9(6):e98621. PubMed ID: 24887068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing tumor centrality in lung stereotactic ablative body radiotherapy (SABR): the effects of variations in bronchial tree delineation and potential for automated methods.
    Ghandourh W; Dowling J; Chlap P; Oar A; Jacob S; Batumalai V; Holloway L
    Med Dosim; 2021 Spring; 46(1):94-101. PubMed ID: 33067108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.